Clapés S, Fernández T, Suárez G

Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 37-40
Archivo PDF: 133.86 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Ashcroft FM, Rorsman P. Diabetes mellitus and the β Cell: the last ten years. Cell. 2012 Mar 16;148(6):1160–71.

2. Inzucchi SE. Clinical practice. Diagnosis of diabetes. N Engl J Med. 2012 Aug 9;367(6):542–50.

3. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010 Oct 29;107(9):1058–70.

4. Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol. 1996 Apr;174(4):1343–53.

5. Anuario Estadístico 2011 [Internet]. Havana: Ministry of Public Health (CU); 2012 [cited 2012 Jun 23]. Available from: http://fi les.sld.cu/dne/ fi les/2012/04/anuario-2011-e.pdf. Spanish.

6. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980 Dec;29(12):1023–35.

7. Fetita LS, Sobngwi E, Serradas P, Calvo F, Gautier JF. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab. 2006 Oct;91(10):3718–24.

8. Loeken MR. Advances in understanding the molecular causes of diabetes-induced birth defects. Soc Gynecol Investig. 2006 Jan;13(1):2–10.

9. Ericksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers. Animal and human studies. Rev Endocr Metab Disord. 2003 Mar;4(1):79–93.

10. González E. Diabetes experimental: etiología de malformaciones congénitas en descendientes de ratas diabéticas. Rev Cubana Endocrinol. 2002;13(1):53–63. Spanish.

11. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med. 2002 Apr;19(4):322–6.

12. Chen CP. Congenital malformations associated with maternal diabetes. Taiwanese J Obstet Gynecol. 2005 Mar 1;44(1):1–7.

13. Wu Y, Viana M, Thirumangalathu S, Loeken MR. AMP-activated protein kinase mediates effects of oxidative stress on embryo gene expression in a mouse model of diabetic embryopathy. Diabetologia. 2012 Jan;55(1):245–54.

14. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006 Jul;116(7):1776–83.

15. Gorrita Y, Núñez N, Fernández T, Clapés S. Malformaciones congénitas en la descendencia de ratas diabéticas [Congenital anomalies in diabetic rats descendants]. Rev Haban Cienc Med. Spanish. Forthcoming.

16. Marcheco B. El programa nacional de diagnóstico, manejo y prevención de enfermedades genéticas y defectos congénitos de Cuba: 1981– 2009. Rev Cubana Genética Comun. 2009;3 (2-3):167–84. Spanish.

17. Guillén M, Valdés L, Lang J. Programa Nacional Cubano de Atención Integral a la Gestante con Diabetes Mellitus. Conferencia. Libro resumen COPAEN 2012. XIII Congreso Latinoamericano de Endocrinología; 2012 May 11; Havana, Cuba. p 11. Spanish.

18. Álvarez AG, García A, Gorbea MH. Pautas conceptuales y metodológicas para explicar los determinantes de los niveles de salud en Cuba. Rev Cubana Salud Pública. 2007;33(2). Spanish.

19. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddigi T, Dignan PS, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med. 2000 Jan–Feb;9(1):14–20.

20. Vigneri R, Squatrito S, Frittitta L. Selective insulin receptor modulators (SIRM): a new class of antidiabetes drugs? Diabetes. 2012 May;61(5):984–5.